Firdausi Qadri Selected Research

Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)

1/2022	Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial.
3/2021	Case Report: Typhoid Fever Complicated by Ileal Perforation in an Urban Slum of Dhaka, Bangladesh.
1/2021	Re-evaluation of population-level protection conferred by a rotavirus vaccine using the 'fried-egg' approach in a rural setting in Bangladesh.
7/2020	Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.
1/2020	Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata.
1/2020	Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever.
8/2010	Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Firdausi Qadri Research Topics

Disease

119	Cholera 11/2022 - 03/2002
74	Infections 10/2021 - 03/2002
32	Typhoid Fever (Typhoid) 11/2022 - 09/2006
32	Diarrhea 11/2021 - 04/2003
6	Inflammation (Inflammations) 01/2022 - 09/2008
6	Dehydration (Water Stress) 01/2021 - 11/2009
6	Convalescence 01/2016 - 05/2003
4	Poliomyelitis (Polio) 01/2019 - 08/2014
4	Bacteremia 01/2016 - 09/2006
3	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2013
3	Bacterial Infections (Bacterial Infection) 10/2020 - 10/2011
3	beta-Thalassemia (Cooley's Anemia) 01/2020 - 01/2018
3	Communicable Diseases (Infectious Diseases) 01/2019 - 12/2011
3	Bacillary Dysentery (Shigellosis) 01/2019 - 05/2003
3	Tetanus 01/2016 - 01/2013
3	Vomiting 09/2014 - 11/2009
2	Japanese Encephalitis 11/2022 - 01/2021
2	COVID-19 03/2022 - 11/2021
2	Hepatitis E 12/2021 - 01/2020
2	Hepatitis B 10/2021 - 11/2014
2	Hepatitis 03/2021 - 01/2020
2	Fever (Fevers) 01/2020 - 03/2014
2	Thalassemia 01/2020 - 01/2018
2	Reinfection 12/2019 - 01/2019
2	Measles 01/2019 - 01/2013
2	Whooping Cough (Pertussis) 01/2016 - 11/2014
2	Diphtheria 11/2014 - 01/2013
1	Severe Acute Respiratory Syndrome 06/2022
1	Coronavirus Infections 03/2022
1	Hepatitis A (Hepatitis, Infectious) 01/2022
1	Shock 01/2022
1	Intestinal Perforation 03/2021
1	Jaundice (Icterus) 03/2021

Drug/Important Bio-Agent (IBA)

57	VaccinesIBA 11/2022 - 07/2005
54	AntigensIBA 11/2021 - 05/2003
44	Cholera Vaccines FDA Link 01/2022 - 01/2004
31	Immunoglobulin A (IgA)IBA 01/2021 - 08/2003
28	Immunoglobulin G (IgG)IBA 03/2022 - 09/2006
27	AntibodiesIBA 03/2022 - 08/2003
25	Cholera ToxinIBA 01/2021 - 08/2003
25	LipopolysaccharidesIBA 01/2021 - 04/2003
17	Conjugate VaccinesIBA 11/2022 - 10/2011
16	O Antigens (O Antigen)IBA 11/2021 - 11/2012
15	Polysaccharides (Glycans)IBA 11/2022 - 06/2013
15	Proteins (Proteins, Gene)FDA Link 07/2020 - 05/2007
12	Immunoglobulin M (IgM)IBA 03/2022 - 01/2010
12	EnzymesIBA 01/2020 - 10/2008
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2005
11	Blood Group Antigens (Blood Groups)IBA 10/2021 - 11/2005
9	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 11/2022 - 01/2013
8	shancholIBA 01/2022 - 10/2011
7	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2022 - 08/2010
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2008
6	TCVSIBA 11/2022 - 01/2019
6	ImmunosorbentsIBA 01/2020 - 02/2009
5	ZincIBA 09/2016 - 01/2004
4	Monoclonal AntibodiesIBA 01/2021 - 06/2005
4	Vitamin A (Retinol)FDA LinkGeneric 11/2020 - 01/2004
4	CytokinesIBA 03/2015 - 08/2011
4	DukoralIBA 10/2013 - 02/2009
3	Complement System Proteins (Complement)IBA 12/2021 - 08/2009
3	cholera vaccine CVD 103-HgRIBA 01/2021 - 08/2006
3	Hemolysin Proteins (Hemolysins)IBA 10/2020 - 03/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 10/2008
3	Rotavirus VaccinesIBA 11/2018 - 04/2015
3	MicronutrientsIBA 11/2016 - 11/2008
3	Peru 15IBA 12/2009 - 08/2005
2	Dihydrotachysterol (AT 10)IBA 11/2021 - 01/2020
2	CarbohydratesIBA 01/2021 - 05/2015
2	Phosphates (Orthophosphate)IBA 01/2021 - 01/2021
2	Lipopolysaccharide ReceptorsIBA 01/2021 - 11/2020
2	Neuraminidase (Sialidase)IBA 01/2021 - 12/2016
2	Hemoglobin EIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2020
2	Drinking WaterIBA 12/2018 - 01/2017
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2018 - 01/2016
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 03/2015
2	InterferonsIBA 01/2018 - 06/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2016
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2016 - 02/2010
2	Interleukin-17 (Interleukin 17)IBA 06/2014 - 06/2012
2	Bacterial Proteins (Bacterial Protein)IBA 05/2013 - 09/2006
2	N 30IBA 01/2013 - 05/2011
2	Messenger RNA (mRNA)IBA 11/2011 - 10/2006
2	Enterotoxins (Enterotoxin)IBA 11/2006 - 07/2005
2	Indicators and Reagents (Reagents)IBA 10/2005 - 01/2004
2	Mannose (D-Mannose)IBA 06/2005 - 08/2003
2	Hemagglutinins (Hemagglutinin)IBA 06/2005 - 08/2003
1	ChAdOx1 nCoV-19IBA 06/2022
1	ElectrolytesIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Bacterial PolysaccharidesIBA 11/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 10/2021
1	Engerix-BIBA 10/2021
1	A 19IBA 03/2021
1	Carrier Proteins (Binding Protein)IBA 03/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021

Therapy/Procedure

10	Therapeutics 01/2020 - 09/2008
6	Fluid Therapy (Oral Rehydration Therapy) 12/2018 - 07/2005
2	Blood Transfusion (Blood Transfusions) 01/2021 - 01/2020